timothy sykes logo

Stock News

Chemours Shares Plunge as Earnings Disappoint Investors

Matt MonacoAvatar
Written by Matt Monaco Reviewed by Jack Kellogg Fact-checked by Tim Sykes
Updated 2/21/2026, 8:22 am ET 2/21/2026, 8:22 am ET | 5 min 5 min read
Chemours Shares Plunge as Earnings Disappoint Investors Thumbnail

Chemours Company (The) stocks have been trading down by -16.59 percent amid environmental cleanup cost concerns and legislative scrutiny.

Materials industry expert:

Analyst sentiment – negative

  1. Market Position & Fundamentals: Chemours (CC) currently faces a challenging market position with a profitability ratio indicating strain, exemplified by a negative profit margin of -5.69%. Despite generating a substantial revenue of $5.782 billion, the company struggles with declining revenue growth over the last three years (-5.83%). The high debt levels, reflected in a total debt-to-equity ratio of 14.61, raise concerns about its financial leverage and long-term sustainability. Meanwhile, the company’s return on equity (ROE) of 18.06% suggests some level of management efficiency, but the negative returns on capital and assets indicate broader operational inefficiencies. The concerning cash flow situation, characterized by a dependency on external financing and a reduced free cash flow generation capacity, further complicates its market outlook.

  2. Technical Analysis & Trading Strategy: A sharp decline in Chemours’ stock price on February 19–20, alongside the failed attempt to maintain the $21 level, has shifted the dominant trend to negative. The stock’s recent pricing at $17.0232 indicates possible support, though volume patterns with surged sell-offs suggest continued downward pressure. With bearish candles forming, traders should consider a short-selling strategy below the $18 level, targeting support at $16.50, with stop-loss orders placed above $20.71. Staying vigilant for reversal patterns is paramount, given the heightened volatility and erratic price movements.

  3. Catalysts & Outlook: Recent earnings reports highlighted operational challenges for Chemours, with Q4 adjusted EPS decline to $0.05 markedly below consensus. Sales performance in key segments failed to meet market expectations. The heavy 19% drop in shares accentuated significant market doubts about the firm’s current trajectory, compounded by management’s muted sales growth forecast. Compared to the broader Materials and Chemicals sectors, Chemours continues to underperform due to lower margins and persistent litigation overhang. A notable resistance level now sits around $21, while $16.50 serves as a current support threshold. Given these conditions, the outlook remains cautious, with no immediate catalysts for a reversal identified.

Candlestick Chart

Weekly Update Feb 16 – Feb 20, 2026: On Saturday, February 21, 2026 Chemours Company (The) stock [NYSE: CC] is trending down by -16.59%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Chemours Company has reported its fourth quarter financials, revealing some challenging figures. The adjusted earnings per share (EPS) came in at $0.05, falling short of the previous year’s $0.09 and missing expectations of $0.07. This shortfall was accompanied by quarterly sales of $1.33 billion, which, while aligned with forecasts, did little to alleviate market concerns over the company’s performance. Management’s guidance indicates optimism for a 3%-5% sequential increase in Q1 2026 sales, with similar expectations for the entire year, targeting around $6.04 billion. However, these growth rates, set against a backdrop of missing earnings expectations, underline the operational pressure Chemours is experiencing, as reflected in the stock’s double-digit decline in after-hours trading.

More Breaking News

Analyzing the key financial ratios offers more insight into Chemours’ current condition. With its operating income indicating low profitability and a gross margin of 17.4%, there’s a glimpse of the tough economic terrain ahead. The company’s leverage remains an area of concern, with a debt to equity ratio significantly high at 14.61. These figures suggest tightened financial conditions, challenging Chemours to balance growth with fiscal health. Furthermore, a negative profit margin hints at underlying inefficiencies, amplifying external concerns around future earnings potential. Whether these financial pressures are cyclical or signal deeper-rooted issues remains a pivotal question for investors.

Conclusion

In summary, the recent challenges highlighted in Chemours’ financial reports have exposed vulnerabilities within its operational framework. With traders seemingly cautious, the lower earnings and underperformance against market projections have set the stage for continued vigilance. As millionaire penny stock trader and teacher Tim Sykes says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.” Going forward, the company’s ability to implement effective strategic responses to guarantee both growth and stability will be critical in influencing trader sentiment and stock performance, amidst an overall challenging economic landscape.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Matt Monaco

Mentor and Trainer at StocksToTrade.com, Lead Mentor at Small Cap Rockets and To The Moon Report
He is a diligent trader and teacher in his To The Moon Report blogs and Small Cap Rockets strategy webinars. He shows up every day, and expects his students to as well. Matt is fond of trading sketchy, volatile OTC stocks with profit potential. His favorite patterns are panic dip buys and breakouts.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”